Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Falkson

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Oncology|January 1, 1992
Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancerC I Falkson, G Falkson, C B Falkson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatmentG Falkson, J J Van Dyk, R Stapelberg, et al.
American Journal of Clinical Oncology|February 1, 1993
A randomized trial of mitomycin-C (M) versus mitomycin-C plus high-dose medroxyprogesterone acetate (MMPA) in the treatment of patients with advanced breast cancerC I Falkson, G Falkson, C B Falkson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancerG Falkson, H L Pretorius, H C Falkson, et al.
Cancer Clinical Trials|January 1, 1980
Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II studyG Falkson, H C Falkson, H E du Plessis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survival of patients treated with combination chemotherapy for metastatic breast cancerG Falkson, D C Tormey, P Carey, et al.
Cancer Research|December 15, 1988
Prognostic factors for survival in hepatocellular carcinomaG Falkson, A Cnaan, A J Schutt, et al.
Investigational New Drugs|January 1, 1994
FIVB plus GM-CSF in metastatic colorectal cancerC I Falkson, G Falkson, H C Falkson, et al.
Medical and Pediatric Oncology|January 1, 1989
Treatment and prognosis of metastatic carcinoma of unknown primary: analysis of 100 patientsA S Alberts, G Falkson, H C Falkson, et al.
Cancer|June 1, 1979
Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy: a study of Cancer and Leukemia Groupe BG Falkson, H C Falkson, O Glidewell, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Oncology|January 1, 1992
Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancerC I Falkson, G Falkson, C B Falkson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatmentG Falkson, J J Van Dyk, R Stapelberg, et al.
American Journal of Clinical Oncology|February 1, 1993
A randomized trial of mitomycin-C (M) versus mitomycin-C plus high-dose medroxyprogesterone acetate (MMPA) in the treatment of patients with advanced breast cancerC I Falkson, G Falkson, C B Falkson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancerG Falkson, H L Pretorius, H C Falkson, et al.
Cancer Clinical Trials|January 1, 1980
Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II studyG Falkson, H C Falkson, H E du Plessis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survival of patients treated with combination chemotherapy for metastatic breast cancerG Falkson, D C Tormey, P Carey, et al.
Cancer Research|December 15, 1988
Prognostic factors for survival in hepatocellular carcinomaG Falkson, A Cnaan, A J Schutt, et al.
Investigational New Drugs|January 1, 1994
FIVB plus GM-CSF in metastatic colorectal cancerC I Falkson, G Falkson, H C Falkson, et al.
Medical and Pediatric Oncology|January 1, 1989
Treatment and prognosis of metastatic carcinoma of unknown primary: analysis of 100 patientsA S Alberts, G Falkson, H C Falkson, et al.
Cancer|June 1, 1979
Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy: a study of Cancer and Leukemia Groupe BG Falkson, H C Falkson, O Glidewell, et al.
Pageof 6